Jonas Lategahn

1.7k total citations
22 papers, 1.1k citations indexed

About

Jonas Lategahn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jonas Lategahn has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Jonas Lategahn's work include Lung Cancer Treatments and Mutations (13 papers), Cancer therapeutics and mechanisms (9 papers) and HER2/EGFR in Cancer Research (9 papers). Jonas Lategahn is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Cancer therapeutics and mechanisms (9 papers) and HER2/EGFR in Cancer Research (9 papers). Jonas Lategahn collaborates with scholars based in Germany, Brazil and Austria. Jonas Lategahn's co-authors include Andrey P. Antonchick, Rajarshi Samanta, Daniel Rauh, Julian Engel, Marina Keul, Hannah L. Tumbrink, Stefan Laufer, Sebastian Bauer, Carsten Schultz‐Fademrecht and Thomas Mühlenberg and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jonas Lategahn

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Lategahn Germany 14 765 358 179 162 44 22 1.1k
Xin Zhai China 16 363 0.5× 369 1.0× 122 0.7× 153 0.9× 41 0.9× 66 695
So Ha Lee South Korea 16 437 0.6× 323 0.9× 71 0.4× 118 0.7× 38 0.9× 49 690
Guoshun Luo China 17 301 0.4× 423 1.2× 87 0.5× 274 1.7× 79 1.8× 46 858
Angel R. Fuentes‐Pesquera United States 14 561 0.7× 274 0.8× 82 0.5× 261 1.6× 89 2.0× 16 888
Asaad Nematalla United States 7 240 0.3× 269 0.8× 101 0.6× 123 0.8× 21 0.5× 13 547
Robert H. Gruninger United States 13 345 0.5× 252 0.7× 74 0.4× 234 1.4× 79 1.8× 14 704
Aurélie Mallinger France 10 151 0.2× 226 0.6× 149 0.8× 234 1.4× 41 0.9× 17 539
Maria Gabriella Brasca Italy 17 276 0.4× 345 1.0× 61 0.3× 186 1.1× 82 1.9× 28 663
Eva Řezníčková Czechia 15 245 0.3× 259 0.7× 85 0.5× 146 0.9× 22 0.5× 44 541
Andrew A. Godfrey United Kingdom 6 266 0.3× 324 0.9× 173 1.0× 278 1.7× 37 0.8× 12 620

Countries citing papers authored by Jonas Lategahn

Since Specialization
Citations

This map shows the geographic impact of Jonas Lategahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Lategahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Lategahn more than expected).

Fields of papers citing papers by Jonas Lategahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Lategahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Lategahn. The network helps show where Jonas Lategahn may publish in the future.

Co-authorship network of co-authors of Jonas Lategahn

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Lategahn. A scholar is included among the top collaborators of Jonas Lategahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Lategahn. Jonas Lategahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gontla, Rajesh, Thomas Mühlenberg, Jörn Weisner, et al.. (2024). Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA. Nature Communications. 15(1). 63–63. 16 indexed citations
2.
Müller, Matthias, et al.. (2020). Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands. ACS Medicinal Chemistry Letters. 11(12). 2484–2490. 31 indexed citations
3.
Lategahn, Jonas, Marina Keul, Hannah L. Tumbrink, et al.. (2020). Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach. Journal of Medicinal Chemistry. 63(20). 11725–11755. 12 indexed citations
4.
Lategahn, Jonas, Harold Hilarion Fokoue, Carlos Maurício R. Sant’Anna, et al.. (2019). A novel scaffold for EGFR inhibition: Introducing N-(3-(3-phenylureido)quinoxalin-6-yl) acrylamide derivatives. Scientific Reports. 9(1). 14–14. 42 indexed citations
5.
Lategahn, Jonas, et al.. (2019). Structure Defines Function: Clinically Relevant Mutations in ErbB Kinases. Journal of Medicinal Chemistry. 63(1). 40–51. 13 indexed citations
6.
Sos, Martin L., Hannah L. Tumbrink, Carsten Schultz‐Fademrecht, et al.. (2019). Targeting EGFR Ex20 mutant lung cancer with the wild type sparing kinase inhibitor PRB001.. Journal of Clinical Oncology. 37(15_suppl). e14718–e14718. 1 indexed citations
7.
8.
Cronin, Shane J. F., Julian Engel, Matthias Baumann, et al.. (2019). Targeting the MKK7–JNK (Mitogen-Activated Protein Kinase Kinase 7–c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors. Journal of Medicinal Chemistry. 62(5). 2843–2848. 18 indexed citations
9.
Schmidt, Martin, Hannah L. Tumbrink, Jonas Lategahn, et al.. (2018). Insights into the Kinetics of the Resistance Formation of Bacteria against Ciprofloxacin Poly(2-methyl-2-oxazoline) Conjugates. Bioconjugate Chemistry. 29(8). 2671–2678. 10 indexed citations
10.
Tesch, Roberta, Christian F. W. Becker, Matthias Müller, et al.. (2018). An Unusual Intramolecular Halogen Bond Guides Conformational Selection. Angewandte Chemie International Edition. 57(31). 9970–9975. 14 indexed citations
11.
Lategahn, Jonas, Marina Keul, & Daniel Rauh. (2017). Lessons To Be Learned: The Molecular Basis of Kinase‐Targeted Therapies and Drug Resistance in Non‐Small Cell Lung Cancer. Angewandte Chemie International Edition. 57(9). 2307–2313. 38 indexed citations
12.
Lategahn, Jonas, Marina Keul, & Daniel Rauh. (2017). Lektion gelernt? Die molekularen Grundlagen von Kinase‐gerichteten Therapien und Wirkstoffresistenz im nicht‐kleinzelligen Lungenkrebs. Angewandte Chemie. 130(9). 2329–2335. 1 indexed citations
13.
Günther, Marcel, Jonas Lategahn, Michael Juchum, et al.. (2017). Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site. Journal of Medicinal Chemistry. 60(13). 5613–5637. 81 indexed citations
14.
Tomassi, Stefano, Jonas Lategahn, Julian Engel, et al.. (2017). Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor. Journal of Medicinal Chemistry. 60(6). 2361–2372. 46 indexed citations
15.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Inhibition wirkstoffresistenter Mutationsvarianten der Rezeptortyrosinkinase EGFR. Angewandte Chemie. 128(36). 11069–11073. 5 indexed citations
16.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Insight into the Inhibition of Drug‐Resistant Mutants of the Receptor Tyrosine Kinase EGFR. Angewandte Chemie International Edition. 55(36). 10909–10912. 52 indexed citations
17.
Engel, Julian, Jonas Lategahn, & Daniel Rauh. (2015). Hope and Disappointment: Covalent Inhibitors to Overcome Drug Resistance in Non-Small Cell Lung Cancer. ACS Medicinal Chemistry Letters. 7(1). 2–5. 77 indexed citations
18.
Samanta, Rajarshi, Jonas Lategahn, & Andrey P. Antonchick. (2012). Metal-free direct oxidative intermolecular diarylation of anilides at ambient temperature assisted by cascade selective formation of C–C and C–N bonds. Chemical Communications. 48(26). 3194–3194. 102 indexed citations
19.
Antonchick, Andrey P., et al.. (2011). Organocatalytic, Oxidative, Intramolecular CH Bond Amination and Metal‐free Cross‐Amination of Unactivated Arenes at Ambient Temperature. Angewandte Chemie International Edition. 50(37). 8605–8608. 351 indexed citations
20.
Antonchick, Andrey P., et al.. (2011). Organokatalytische, oxidative, intramolekulare C‐H‐Bindungsaminierung und metallfreie Kreuzaminierung nichtaktivierter Arene bei Raumtemperatur. Angewandte Chemie. 123(37). 8764–8767. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Zhai Breakdown of academic impact, for papers by So Ha Lee Breakdown of academic impact, for papers by Guoshun Luo Breakdown of academic impact, for papers by Angel R. Fuentes‐Pesquera Breakdown of academic impact, for papers by Asaad Nematalla Breakdown of academic impact, for papers by Robert H. Gruninger Breakdown of academic impact, for papers by Aurélie Mallinger Breakdown of academic impact, for papers by Maria Gabriella Brasca Breakdown of academic impact, for papers by Eva Řezníčková Breakdown of academic impact, for papers by Andrew A. Godfrey
Rankless by CCL
2026